• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    TELA Bio, Inc. - Common stock (NQ: TELA )

    2.910 +0.030 (+1.04%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about TELA Bio, Inc. - Common stock

    < Previous 1 2 3 4 Next >
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference
    From TELA Bio, Inc.
    Via GlobeNewswire
    Deep Dive Into TELA Bio Stock: Analyst Perspectives (6 Ratings)
    Via Benzinga
    TELA Bio Reports Third Quarter 2024 Financial Results
    Reiterates 2024 Revenue Guidance and Expects Recently Implemented Operational Efficiency Improvements to Reduce Operating Expenses in 2025 
    From TELA Bio, Inc.
    Via GlobeNewswire
    Demystifying TELA Bio: Insights From 6 Analyst Reviews
    Via Benzinga
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    From TELA Bio, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
    From TELA Bio, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce Third Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
    Via Benzinga
    Exposures Fossil Fuels
    S&P 500 Gains 1%; Home Depot Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
    Via Benzinga
    TELA Stock Earnings: TELA Bio Misses EPS, Misses Revenue for Q2 2024
    TELA stock results show that TELA Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce Second Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Appoints Jeffrey Blizard to its Board of Directors
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Appoints Greg Firestone as Chief Commercial Officer
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q1 2024
    TELA stock results show that TELA Bio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    TELA Bio Reports First Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce First Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
    Targets the more than 665,000 inguinal hernia procedures performed annually in the United States (U.S.) 
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
    Howard N. Langstein, MD, FACS joins innovative MedTech company to leverage his vast experience to help other surgeons optimize clinical outcomes in plastic and reconstructive surgery 
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023
    TELA stock results show that TELA Bio missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.